Synthesis of degradable cationic carbosilane dendrimers based on Si-O or ester bonds by Rodríguez Prieto, Tamara et al.








This work is licensed under a  
Creative Commons Attribution-NonCommercial-NoDerivatives  
4.0 International License. 
       
 
 
Document downloaded from the institutional repository of the University of 
Alcala: http://dspace.uah.es/ 
 
This is a postprint version of the following published document: 
 
Rodríguez Prieto, T., Barrios Gumiel, A., Mata De La Mata, Francisco J. De La, 
Sánchez-Nieves Fernández, J. & Gómez Ramírez, R. 2016, "Synthesis of 
degradable cationic carbosilane dendrimers based on Si-O or ester bonds", 
Tetrahedron, vol. 72, no. 39, pp. 5825-5830.  
 
 
Available at http://dx.doi.org/10.1016/j.tet.2016.07.084 
 
 









































































Synthesis of degradable cationic carbosilane dendrimers based 
on Si-O or ester bonds 
Tamara Rodríguez-Prieto,a,1 Andrea Barrios-Gumiel,a,1 F. Javier de la Mata,a,b Javier Sánchez-
Nievesa,b,* and Rafael Gómeza,b,* 
a Department of Química Orgánica y Química Inorgánica, Universidad de Alcalá, Campus 
Universitario, E-28871 Alcalá de Henares (Madrid) Spain; email: javier.sancheznieves@uah.es; 
rafael.gomez@uah.es. 
b Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN). 
1 These authors contribute equally to this work. 
*Revised Manuscript





































































Several cationic carbosilane dendritic molecules have been synthesized containing two different types 
of degradable bonds: Si-O and ester bonds. The first type of systems was prepared by reacting carbosilane 
dendrimers containing peripheral Si-Cl bonds with first generation dendrons presenting a –OH function at 
the focal point and amine peripheral functions. The second type of systems was prepared by esterification 
between a dendrimer containing acid groups and an alcohol amine. The stability in water of both types of 
cationic systems was evaluated. 





































































Non-viral gene carriers are synthetic systems designed to deliver plasmids, nucleic acids (DNA and 
RNA) or oligonucleotides to cells with the aim to treat deseases.1 Several systems have been designed 
following controlled procedures for this purpose.2-9 These carriers interact with nucleic acids, usually 
electrostatically, compacting them and preventing their degradation. Therefore, cationic macromolecules 
have been widely explored as nucleic acid vectors.10 However, the intrinsic toxicity of cationic 
macromolecules is a major drawback and the search of degradable derivatives is a key target of this 
research area, since degradation of the cationic macromolecule will lead to smaller systems, favoring also 
their clearance from the body. 
One type of non-viral systems widely studied are dendrimers, which are spherical macromolecules 
with well-defined size and structure, monodisperse, flexible, and with a multivalent molecular surface.11-13 
The controlled synthetic procedure minimizes structural defects and allows establishing structure-activity 
relationships more easily than for polymeric materials. Cationic dendrimers containing different skeletons 
have been explored for gene therapy, based on the multicationic charge on dendrimers surface.8,14-19 
Consequently, the development of dendrimers with biodegradable structures leading to less toxic 
fragments is in the center of attention.20 The main type of degradable systems contains aliphatic polyester 
moieties, 20-23 which usually also gives hydrophilicity to the dendrimer scaffold. It is assume that ester 
bonds will be degraded in biological environment due to action of enzymes or well by the pH conditions 
of some body or cell regions. In fact, several studies indicate that hydrolysis is mainly produced at pH 
ranging from 7 to 9 24,25 and is accelerated in the presence of estereases.26 
A different approach has been the preparation of carbosilane dendrimers with unstable peripheral Si-O 
bonds close to the cationic charge, which were prepare by alcoholysis of Si-Cl bonds.27-29 These water-
soluble derivatives bind oligonucleotides and siRNA, protect them from degradation and transport them to 
the interior of a range of cell types.27,28,30-33 The hydrophobic framework of these macromolecules, formed 
by C-C and Si-C bonds, is important for this application, making easier the trespassing of cell membranes 




































































degraded by water and therefore, these dendrimers have limited applications beyond in vitro assays. Other 
type of degradable carbosilane dendrimers, also very unstable in protic environment, has been described 
containing an acyloxysilane framework.36 
With the aim to avoid the problem of fast hydrolysis in degradable carbosilane dendrimers, we have 
designed new cationic systems through two different strategies: with inner Si-O bonds or with peripheral 
ester bonds. The first type of dendrimers has been prepared by coupling carbosilane dendrons with 
carbosilane dendrimers. The dendrons present amine peripheral functions and a hydroxyl moiety at the 
focal point whereas dendrimers are decorated with Si-Cl bonds. For the second type of systems, 
dendrimers with acid groups have been synthesized followed by and acid-alcohol esterification. The 
characterization and water stability of these new dendritic macromolecules are also here discussed. 
 
2. Results and Discussion 
For the synthesis of dendrimers with a hydrolysable Si-O bond we have employed dendrimer cores 
derived from a Si atom (eight Si-Cl bonds)37 or from a polyphenoxo group (six Si-Cl bonds),38 and a first 
generation carbosilane dendron (two amine –NMe2 functions, named as HOROG1(NMe2)2, R = (CH2)2, 
C6H4) with a hydroxyl moiety at the focal point, coming from ethyleneglycol (R = (CH2)2) or 
hydroquinone (R = C6H4) fragments.39 
 
Scheme 1. Synthesis of cationic dendrons with Si-O bonds (R = C2H4, C6H4). i) NEt3; ii) MeI. 
The reactions of dendrimers with wedges in the presence of NEt3 afforded the corresponding amine-
terminated dendrimers 1 (Si atom core, ethyleneglycol focal point), 2 (Si atom core, hydroquinone focal 
point), and 3 (polyphenoxo core, ethyleneglycol focal point) (scheme 1, figure S1). Transformation of the 




































































showed the shifting for the MeSi groups from δ ca. 0.3 (MeSiCl) to δ ca. 0.0 (MeSiO) and the 29Si NMR 
spectra also showed this change for the outermost Si atoms from δ ca. 30 (MeSiCl) to δ ca. 5 (MeSiO). 
 
Figure 1. Drawing of cationic dendrimers 4-6.  
The respective cationic derivatives 4 (Si atom core, ethyleneglycol focal point), 5 (Si atom core, 
hydroquinone focal point), and 6 (polyphenoxo core, ethyleneglycol focal point) were easily obtained after 




































































very polar solvents as DMSO. Quaternization of the nitrogen atoms was mainly identified by the 
resonances in the 1H NMR spectra at about δ 3.0 for the methyl groups bound to this atom, shifted from δ 
ca. 2.2 in the neutral compounds. 
The stability of the Si-O bonds of compounds 4-6 were tested by addition of one eq. of H2O per Si-O 
bond to DMSO-D6 solutions of these compounds and their evolutions were followed by 1H-29Si HMBC 
NMR spectroscopy. These processes showed the hydrolysis of the Si-O-C bonds by means of the 
disappearance of the cross-peak belonging to the silicon atom of these bonds (δ ca. 18) and the appearing 
of a new resonance at δ ca. 10 corresponding to Si-OH systems, which further evolved to Si-O-Si bonds (δ 
ca. 5). The rate of hydrolysis of Si-OR bonds is clearly dependent of pendant R groups. In the case of 
compounds 4 and 6 (R = O(CH2)2O), obtained from dendrons with ethyleneglycol at the focal point, the 
breakup of this bond is produced immediately. The same procedure for dendrimer 5 (R = OC6H4O) kept 
the system unchanged, being necessary 20 fold excess H2O to produce the complete hydrolysis. Hence, the 
hydrolysis of cationic dendrimers 4-6 would give first generation cationic dendrons of the type 
HOROG1(NMe3+)2 and also silicone-type polymers. Due to the small size of dendrons they present very 
low toxicity and they would be easily clearance from the body.40 
To afford the second type of dendrimers with degradable ester bonds, we have followed the next 
synthetic procedure (Scheme 2): thiol-ene addition of mercaptopropionic acid to allyl-decorated 
dendrimers, coupling of the previous acid dendrimers with N,N-dimethylamineethanol and finally addition 
of MeI. As in previous dendrimers, two different cores have been employed, Si atom and trisubstituted 
phloroglucinol. 
 
Scheme 2. Synthesis of cationic dendrimers with ester bonds. i) HS(CH2)2CO2H, DMPA, hν; ii) 




































































Hence, the first step is the reaction of allyl derivatives GnXAm (X = Si, n = 1, m = 8; X = Si, n = 2, m = 
16; X = C6H3O3, n = 2, m = 12) with mercaptopropionic acid under UV irradiation, obtaining the 
respective acid dendrimers GnX(S-CO2H)m (X = Si, n = 1, m = 8 (7); X = Si, n = 2, m = 16 (8); X = 
C6H3O3, n = 2, m = 12 (9)) in high yields (> 85%). NMR spectroscopy clearly showed this transformation 
with the disappearance of the resonances belonging to the allyl groups and the presence of the resonances 
belonging to the new alkyl chain formed (Si(CH2)3)S) and to the new chain introduced (S(CH2)2)CO), 
both in the 1H NMR and in the 13C NMR. 
Next, reaction of esterification between dendrimers 7-9 and the alcohol-amine HO(CH2)2NMe2, in the 
presence of coupling agents, led to the corresponding ester dendrimers GnX(S-CO2(CH2)2NMe2)m (X = Si, 
n = 1, m = 8 (10); X = Si, n = 2, m = 16 (11); X = C6H3O3, n = 2, m = 12 (12)) in high yields (> 80%). The 
presence of the ester bond was confirmed in the 1H NMR spectrum by the resonance around δ ca. 4.20 for 
the CH2O group and in the 13C NMR spectrum by the resonance at about δ ca. 170 for the carbon atom of 
the carbonyl group. Moreover, the resonances for the outer chain (CH2)2NMe2 were also observed. 
Finally, quaternization of the amine groups with excess MeI allowed obtaining the goal cationic 
dendrimers GnX(S-CO2(CH2)2NMe3+)m (X = Si, n = 1, m = 8 (13); X = Si, n = 2, m = 16 (14); X = 
C6H3O3, n = 2, m = 12 (15), Figure 2) in high yields (> 90%). Clearly, the 1H NMR spectra showed the 
shifting of the methyl groups bound to the nitrogen atom from ca. δ ca. 2.20 to δ ca. 3.20, whilst both 1H 
and 13C NMR spectra also showed the presence of the ester linkage. The stability of these derivatives was 
checked by 1H NMR spectroscopy. Cationic dendrimers kept unaltered in D2O solutions even after heating 
at 40 ºC. It is important to note that the breaking off of the ester bond would lead to acid or carboxylate 





































































Figure 2. Drawing of cationic dendrimers 13-15. 
 
3. Conclusions 
Cationic carbosilane dendrimers with degradable bonds can be prepared following two different 
approachs: 1) by reacting dendrimers with Si-Cl peripheral bonds with amine dendrons containing a 
hydroxyl group at the focal point; 2) by reacting dendrimers with acid peripheral groups with an alcohol-




































































Dendrimers with internalized Si-O bonds were very water unstable, although the presence of aryl 
groups attached to the oxygen atom of Si-OR fragment notably reduces hydrolysis rate with respect to 
compounds with an alkyl chain attached to this atom. Thus, these compounds would be rejected for future 
biomedical assays. On the other hand, dendrimers with ester bonds show stability in water media and 
could be adequate candidates to study their capability as carriers for drug or gene delivery. 
 
4. Experimental Section 
4.1. General Considerations. All reactions were carried out under inert atmosphere and solvents were 
purified from appropriate drying agents when necessary. NMR spectra were recorded on a Varian Unity 
VXR-300 (300.13 (1H), 75.47 (13C) MHz) or on a Bruker AV400 (400.13 (1H), 100.60 (13C), 40.56 (15N), 
79.49 (29Si) MHz). Chemical shifts (δ) are given in ppm. 1H and 13C resonances were measured relative to 
internal deuterated solvent peaks considering TMS = 0 ppm, meanwhile 15N and 29Si resonances were 
measured relative to external MeNO and TMS, respectively. When necessary, assignment of resonances 
was done from HSQC, HMBC, COSY, TOCSY and NOESY NMR experiments. Elemental analyses were 
performed on a LECO CHNS-932. Mass Spectra were obtained from a Thermo Scientific and an Agilent 
6210. Thiol-ene reactions were carried out employing a HPK 125 W mercury lamp from Heraeus 
Noblelight with maximum energy at 365 nm, in normal glassware under an inert atmosphere. Compounds 
NEt3, MeI, HS(CH2)2CO2H, 2,2’-dimethoxy-2-phenylacetophenone (DMPA), N,N-dimetylaminopyridine 
(DMAP), HO(CH2)2NMe2, and N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDCI) 
were obtained from commercial sources. Compounds [G1Si(Cl)8],37 [G1O3(Cl)6],38 [HOROG1(S-NMe2)2] 
(R = (CH2)2, C6H4),42 [G1SiA8], [G2SiA16], and [G2O3A12]38 were synthesized as published.  
4.2. Synthesis of selected compounds. 
The synthesis of all compounds is described in Supporting Information, collecting here a selection. 
Dendrimer 1. To a solution of [G1Si(Cl)8] (0.150 mg, 0.103 mmol) in THF (50 ml) was added NEt3 
(1.65 mmol) and [HOROG1(S-NMe2)2] (R = (CH2)2) (0.350 g, 0.825 mmol) and the reaction was stirred 




































































ml), the solution was filtered and volatiles were removed under vacuum, obtaining 1 as a yellowish oil 
(0.32 g, 74 %). Data for 1: 1H NMR (CDCl3): -0.09 (s, 24H, Si(CH3)2); 0.01 (s, 12H, Si(CH3)CH2CH2S); 
0.08 (s, 24H, Si(CH3)2O); 0.54 (m, 32H, CH2Si); 0.64 (m, 8H, OCH2CH2CH2CH2Si); 0.89 (t, 16H, 
SiCH2CH2S); 1.34 (m, 24H, CH2CH2Si); 1.58 (m, 8H, OCH2CH2CH2CH2Si); 2.24 (s, 48H, N(CH3)2); 
2.48 (t, 16H, SiCH2CH2S); 2.53 (t, 16H, SCH2CH2N); 2.61 (t, 16H, SCH2CH2N); 3.45 (m, 16H, 
OCH2CH2O); 3.70 (t, 8H, OCH2CH2CH2CH2Si); 13C NMR (CDCl3): -5.3,-4.9, -1.8 (SiCH3); 13.5, 17.8, 
17.9, 18.6, 19.1, 19.9, 20.4, 21.1 (CH2Si and CH2CH2Si); 14.5 (SiCH2CH2S); 27.6 (SiCH2CH2S); 29.7 
(SCH2CH2N); 33.6 (OCH2CH2CH2CH2Si); 45.4 (N(CH3)2); 59.3 (SiCH2CH2S); 62.0 
(OCH2CH2CH2CH2Si); 71.0, 72.1 (OCH2CH2O); 15N NMR (CDCl3): 27.5; 29Si NMR (CDCl3): 2.8 
(SiMe), 18.0 (SiMe2O). Elemental analysis (C192H444N16O8S16Si21, FW = 4208.52 g mol-1): C, 54.79; H, 
10.63; N, 5.33; S, 12.19; Exp.: C, 53.10; H, 11.46; N, 5.36; S, 11.94. 
Dendrimer 4. Compound 1 (0.110 g, 0.026 mmol) was solved in THF (50 mL) and MeI (0.83 mmol 
(excess 32 fold)) was added. The solution was stirred for 16 h. Next, volatiles were removed under 
vacuum to 25 mL and Et2O was added (25 mL). The solution was filtered off and 4 was obtained as 
yellow powder (0.154 g, 91 %). Data for 4: 1H NMR (DMSO-d6): -0.09 (s, 24H, Si(CH3)2); -0.07 (s, 12H, 
Si(CH3)CH2CH2S); 0.03 (s, 24H, Si(CH3)2O); 0.56 (m, 40H,CH2Si); 0.86 (t, 16H,SiCH2CH2S); 1.32 (m, 
8H, OCH2CH2CH2CH2Si); 1.42 (m, 8H,CH2CH2Si); 1.51 (m, 16H,CH2CH2Si); 1.67 (m, 8H, 
OCH2CH2CH2CH2Si); 2.62 (t, 16H, SiCH2CH2S); 2.89 (t, 16H, SCH2CH2N); 3.08 (s, 72H, N(CH3)3); 
3.36 (m, 16H, OCH2CH2O); 3.50 (m,16H, SCH2CH2N); 3.87 (m, 8H, OCH2CH2CH2CH2Si); 13C NMR 
(DMSO-d6): -5.8 (Si(CH3)); 12.2, 12.9, 17.8, 17.9, 18.6, 19.1, 19.4, 20.4 (CH2Si and CH2CH2Si); 13.5 
(SiCH2CH2S); 23.0 (SiCH2CH2S); 26.2 (SCH2CH2N); 32.5 (OCH2CH2CH2CH2Si); 51.6 (N(CH3)3); 59.7 
(OCH2CH2CH2CH2Si); 63.9 (CH2N); 69.3, 71.5 (OCH2CH2O); 15N NMR (DMSO-d6): 50.6; 29Si NMR 
(DMSO-d6): 3.0 (SiMe), 18.0 (SiMe2O). Elemental analysis (C268H611O16N16Si29, FW = 6479.54 g mol-1): 
C, 42.38;H, 8.13; N, 2.77; S, 6.77; Exp.: C, 43.10; H, 7.46; N, 2.36; S, 6.94. 
Dendrimer 7. Compound G1SiA8 (0.150 g, 0.215 mmol), HS(CH2)2CO2H (0.183 g, 1.724 mmol) were 




































































mixture was desoxygenated and stirred under UV light for 2 h. Afterward, more DMPA was added (2.0 % 
mol per allyl group), and the mixture was again desoxygenated and stirred under UV light for 2 h. more. 
Then, volatiles were removed under vacuum and compound 7 was purified by size exclusion 
chromatography (acetone) to afford pale yellow oil (0.26 g, 78 %). A similar yield was obtained by 
treating an unpurified MeOH solution of compound 7 with excess NaHCO3, then filtering off the solution, 
resolving the white powder in water and acidifying the solution with HCl to pH below 3 and finally 
extracting compound 7 with ethyl acetate, drying with Na2SO4 and removing solvent under vacuum. Data 
for 7: 1H NMR (MeOD-d4): 0.04 (s, 12 H, SiMe), 0.68 (m, 32 H, CH2Si), 1.44 (m, 8 H, 
SiCH2CH2CH2Si), 1.64 (m, 16 H, CH2CH2CH2S), 2.61 (m, 32 H, CH2S), 2.78 (m, 16 H, CH2CO); 13C 
NMR (MeOD-d4): -4.5 (SiMe), 14.4 (CH2Si), 18.7 (CH2Si), 19.8, 19.9, 25.5 (CH2), 27.9 (CH2CO), 35.9 
and 36.8 (CH2S), 175.7 (CO); 29Si NMR (MeOD-d4): 0.7 (Si(CH2)4), 2.5 (SiMe). Elemental analysis 
(C64H124O16S8Si5, MW = 1546.61): C, 49.70; H, 8.08; S, 16.59. Exp.: C, 49.01; H, 7.79; S, 16.13. 
Dendrimer 10. Compound 7 (0.150 g, 0.105 mmol) was dissolved in DMF (5 mL) and DMAP (0.122 
g, 1.00 mmol) and HO(CH2)2NMe2 (0.082 g, 0.920 mmol) were added to the solution. This solution was 
stirred for 15 min. and solid EDCI (0.192 g, 1.00 mmol) was added. The mixture was stirred for 3 d., the 
solvent was evaporated and the remaining oil was purified by size exclusion chromatography in acetone, 
yielding 10 as pale yellow oil (0.153 g, 69%). Data for 10: 1H NMR (CDCl3): -0.09 (s, 12 H, SiMe), 0.53 
(m, 32 H, CH2Si), 1.22 (m, 8 H, SiCH2CH2CH2Si), 1.50 (m, 16 H, CH2CH2CH2S), 2.30 (s, 48 H, NMe2), 
2.48 (m, 16 H, CH2S), 2.60 (m, 32 H, CH2S and CH2CO), 2.72 (m, 16 H, CH2N), 4.18 (m, 16 H, CH2O); 
13C NMR (CDCl3): -5.1 (SiMe), 13.5 (CH2Si), 17.9 (CH2Si), 18.4, 24.1 (CH2), 26.8 (CH2CO), 34.7 and 
35.8 (CH2S), 45.3 (NMe2), 57.4 (CH2N), 61.8 (CH2O), 172.2 (CO); 29Si NMR (CDCl3): 0.4 (Si(CH2)4), 
2.4 (SiMe). Elemental analysis (C96H196N8O16S8Si5, MW = 2115.57): C, 54.50; H, 9.34; N: 5.30; S, 12.13. 
Exp.: C, 55.67; H, 9.79; N: 4.89; S, 15.63. 
Dendrimer 13. Dendrimer 10 (0.100 g, 0.047 mmol) was dissolved in DMF/THF (10/30 mL) and MeI 
was added (0.080 g, 0.546 mmol). The mixture was stirred for 24 h. THF and excess MeI was removed 




































































solid was washed again with Et2O/THF (20/20 mL) and finally Et2O (40 mL) rendering 13 as a yellowish 
solid (0.14 g, 91 %). Data for 13: 1H NMR (DMSO-d6): -0.07 (s, 12 H, SiMe), 0.53 (m, 32 H, CH2Si), 
1.28 (m, 8 H, SiCH2CH2CH2Si), 1.48 (m, 16 H, CH2CH2CH2S), 2.49 (CH2S), 2.68 (broad m, 32 H, CH2S 
and CH2CO), 3.14 (s, 72 H, NMe3+), 3.69 (m, 16 H, CH2N), 4.18 (m, 16 H, CH2O); 13C NMR (DMSO-
d6): -4.2 (SiMe), 13.4 (CH2Si), 18.4, 24.2 (CH2), 25.7 (CH2CO), 34.7 and 35.1 (CH2S), 53.1 (NMe3+), 
58.0 (CH2O), 64.1 (CH2N), 170.8 (CO); 29Si NMR (DMSO-d6): 0.4 (Si(CH2)4), 2.4 (SiMe). Elemental 
analysis (C104H220I8N8O16S8Si5, MW = 3251.09): C, 38.42; H, 6.82; N: 3.45; S, 7.89. Exp.: C, 38.03; H, 
6.26; N: 4.89; S, 7.23. 
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